L-BLP25 vaccine plus letrozole induces a TH1 immune response and has additive antitumor activity in MUC1-expressing mammary tumors in mice. [electronic resource]
Producer: 20121105Description: 2861-71 p. digitalISSN:- 1557-3265
- Animals
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Aromatase Inhibitors
- Cancer Vaccines -- pharmacology
- Cyclophosphamide -- administration & dosage
- Estradiol -- administration & dosage
- Estrogen Antagonists -- pharmacology
- Female
- Interferon-gamma -- biosynthesis
- Interleukin-12 -- biosynthesis
- Letrozole
- Mammary Neoplasms, Animal -- drug therapy
- Membrane Glycoproteins -- pharmacology
- Mice
- Mucin-1 -- biosynthesis
- Neoplasms, Hormone-Dependent -- drug therapy
- Nitriles -- pharmacology
- Random Allocation
- Tamoxifen -- pharmacology
- Th1 Cells -- immunology
- Triazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.